This session highlights AstraZeneca's strategic focus on rare diseases, addressing growth opportunities through innovative therapies. Key insights from leaders demonstrate how emerging markets and new medicines are paving the way for sustained revenue growth. Anticipated product launches and a robust pipeline are crucial for long-term success, particularly amid evolving patient needs and market dynamics.
Forgot password?
Don't have an account? Sign Up